One limitation of our work is the lack of data from IBD tissues, but the work from Aschenbrenner et al36 strongly demonstrates the importance of IL‐10 in the control of IL‐23 in gut monocytes, which suggests identical mechanism are also operational in IBD. This evidence concerns the gene IL23A and inflammatory bowel disease.